• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Erythropoiesis-stimulating agents for anemia of cancer or of chemotherapy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Technologies to reduce errors in dispensing and administration of medication in hospitals: clinical and economic analyses
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Opportunity costs associated with technology expansion in the MUHC
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The Impella percutaneous ventricular assist device
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Subthalamic deep brain stimulation (DBS): clinical efficacy, safety and cost compared to medical therapy for the treatment of Parkinson's Disease
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [In vitro fertilization: comparative profile of European and Oceania countries]
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Clinical efficacy and cost of Allogenic Acellular Dermal Matrix (AADM) in implant-based breast reconstruction of post mastectomy cancer patients
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of Collatamp-G for infection prophylaxis in cardiac surgery
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea: an update
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for treatment of Barrett's esophagus: A systematic review and cost analysis
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Sentinel lymph node biopsy in breast cancer management: technical aspects]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting Beta2-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation
2009     Technology Assessment at SickKids (TASK) Systematic review on orchidopexy for the Canadian Paediatric Surgical Wait Times project
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical diclofenac for the treatment of musculoskeletal pain unrelated to osteoarthritis: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pyxis and medDISPENSE automated medication dispensing systems: a review of the clinical benefits and harms, cost-effectiveness, and guidelines for use
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological management of depression in Parkinson's disease: evidence for antidepressant of choice
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological interventions for weight loss: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oxybutynin, tolterodine, and darifenacin: review of cognitive adverse events
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared to fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: supplementary analyses relating to risk of infection from an unknown virus
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) n-3 lipids for patients on total parenteral nutrition: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Minimal access lobectomy for lung cancer patients: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009     Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical testing in colorectal cancer screening of average risk individuals: economic evaluation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography for pediatric patients: review of clinical effectiveness and indications for use
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins: review of the comparative effectiveness for various indications
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Specialty mattresses for the prevention and management of pressure ulcers: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Benzodiazepines for the treatment of post traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Descemet stripping automated endothelial keratoplasty: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Hyperbaric oxygen therapy for autism: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Casting for foot orthotics: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for mood disorders: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for adults with axis II disorders: a review of clinical effectiveness
2009     Institute for Clinical Evaluative Sciences (ICES) Blood glucose test strip use: patterns, costs and potential cost reduction associated with reduced testing
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for anxiety: a review of the clinical effectiveness
2009     Institute for Clinical Evaluative Sciences (ICES) What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy in the treatment of schizophrenia: a review of the clinical effectiveness
2009     Medical Advisory Secretariat (MAS) Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009     Institute for Clinical Evaluative Sciences (ICES) Registry of the Canadian Stroke Network. Report on the 2004/05 Ontario Stroke Audit
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pathogen reduction technologies for blood products: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Lithotripsy for kidney stones or gallstones: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Addendum to the Canadian Agency for Drugs and Technologies in Health guidelines for the economic evaluation of health technologies: specific guidance for oncology products
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Reuse of single use medical devices]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Carotid artery stenting versus carotid endarterectomy: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Elective endovascular abdominal aortic aneurism repair versus open surgery: a review of the clinical and cost-effectiveness
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) [The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of foot care instruments: a review of the guidelines
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Curative treatment for esophageal cancer: systematic review of neoadjuvant therapy and chemoradiotherapy alone: summary]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy: Clinical- and cost-effectiveness analyses
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Resin-bonded fixed bridges and conventional fixed bridges: a review of the advantages and disadvantages and indications
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Foot care for patients with peripheral vascular disease: a review of the guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone for the treatment of alcohol dependence in individuals with co- dependencies: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone in combination with acamprosate for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Organic acid testing for autism: a review of the diagnostic accuracy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis: a review of the cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraperitoneal chemotherapy for ovarian cancer patients: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib for post-operative pain management: a review of the clinical benefit and harm
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Indirect evidence: indirect treatment comparisons in meta-analysis
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral care sponges for long-term care patients: a review of the clinical-effectiveness
2009     Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasonography in small emergency departments: a systematic review of the guidelines and clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for the treatment of trigeminal neuralgia and temporomandibular joint dysfunction: a review of the clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pelvic floor repair systems: a review of the clinical-effectiveness, cost- effectiveness, and guidelines
2009     Institute of Health Economics (IHE) Effectiveness of organizational interventions for the prevention of stress in the workplace
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for headaches in adults: a review of clinical-effectiveness and safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Australian sheepskins for the management of pressure ulcers: a review of the clinical-effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of lidocaine on adults with open wounds: a review of the safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Methadone for the management of pain in patients with opioid addiction: a review of the evidence and guidelines for dosing recommendations
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Speech and language therapy for children of preschool age: a review of the clinical-effectiveness and quality of life
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Specifications of endosseous dental implants: a review of the advantages, disadvantages, and success rates
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Morphogenetic bone for fracture healing: a review of the clinical-effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative screening for Methicillin-Resistant Staphylococcus aureus (MRSA) infection: a review of the clinical-effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) At home, pre-operative skin preparation: a review of the clinical-effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid response testing for the detection of clostridium difficile: a review of the diagnostic accuracy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Metal-ceramic and porcelain dental crowns: a review of clinical and cost- effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovenous laser therapy for varicose veins: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Microprocessor-controlled prosthetic knees (C-Leg) for patients with above-knee amputations: a review of the clinical- and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Vasopressin as first-line therapy for cardiac arrest: a review of the guidelines and clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Devices for endometrial ablation therapy in the outpatient setting: clinical- and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fluoridated water for cavity prevention: a review of the clinical-effectiveness, cost-effectiveness, and guidelines